Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
19 02 2019
Historique:
received: 19 04 2018
revised: 12 12 2018
accepted: 25 01 2019
entrez: 21 2 2019
pubmed: 21 2 2019
medline: 11 4 2020
Statut: ppublish

Résumé

We used whole-organ mapping to study the locoregional molecular changes in a human bladder containing multifocal cancer. Widespread DNA methylation changes were identified in the entire mucosa, representing the initial field effect. The field effect was associated with subclonal low-allele frequency mutations and a small number of DNA copy alterations. A founder mutation in the RNA splicing gene, ACIN1, was identified in normal mucosa and expanded clonally with an additional 21 mutations in progression to carcinoma. The patterns of mutations and copy number changes in carcinoma in situ and foci of carcinoma were almost identical, confirming their clonal origins. The pathways affected by the DNA copy alterations and mutations, including the Kras pathway, were preceded by the field changes in DNA methylation, suggesting that they reinforced mechanisms that had already been initiated by methylation. The results demonstrate that DNA methylation can serve as the initiator of bladder carcinogenesis.

Identifiants

pubmed: 30784602
pii: S2211-1247(19)30132-9
doi: 10.1016/j.celrep.2019.01.095
pii:
doi:

Substances chimiques

ACIN1 protein, human 0
Nuclear Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2241-2256.e4

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Tadeusz Majewski (T)

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Hui Yao (H)

Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Jolanta Bondaruk (J)

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Woonbok Chung (W)

Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, PA, USA.

Sangkyou Lee (S)

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

June Goo Lee (JG)

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Shizhen Zhang (S)

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

David Cogdell (D)

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Guoliang Yang (G)

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Woonyoung Choi (W)

Johns Hopkins Greenberg Bladder Cancer Institute, Johns Hopkins University, Baltimore, MD, USA.

Colin Dinney (C)

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

H Barton Grossman (HB)

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Christopher Logothetis (C)

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Steven E Scherer (SE)

Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.

Charles C Guo (CC)

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Li Zhang (L)

Department of Environmental Health, University of Cincinnati, Cincinnati, OH, USA.

Peng Wei (P)

Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

John N Weinstein (JN)

Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Jean-Pierre Issa (JP)

Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, PA, USA.

Keith Baggerly (K)

Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: kabagger@mdanderson.org.

David J McConkey (DJ)

Johns Hopkins Greenberg Bladder Cancer Institute, Johns Hopkins University, Baltimore, MD, USA. Electronic address: dmcconk1@jhmi.edu.

Bogdan Czerniak (B)

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: bczernia@mdanderson.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH